Case report: Diabetic microangiopathic hemolytic anemia and thrombocytopenia with antiphospholipid syndrome

American Journal of the Medical Sciences

Volumn 311, Issue 3, 1996, Pages 148-151

  Morita, Hiroyuki ^a   Suwa, Tetsuya ^a   Daidoh, Hisashi ^a   Takeda, Noriyuki ^a   Ishizuka, Tatsuo ^a   Yasuda, Keigo ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Antiphospholipid syndrome; Diabetic microangiopathy; Microangiopathic hemolytic anemia; Thrombocytopenia

Indexed keywords

IMMUNOGLOBULIN G; LACTATE DEHYDROGENASE; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; DIABETIC MICROANGIOPATHY; DISEASE ASSOCIATION; ERYTHROCYTE TRANSFUSION; HEMODIALYSIS; HEMOLYTIC ANEMIA; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTIAL THROMBOPLASTIN TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0029928860     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199603000-00009     Document Type: Article

References (14)

1. Brunning RD, Jacob HS, Brenckman WD, Jimenez-Pasquau F, Goetz FC. Fragmentation haemolysis in patients with severe diabetic angiopathy. Br J Haematol. 1976;34:283-9.
2. Harris EN. Antiphospholipid antibodies. Br J Haematol. 1990;74:1-9.
3. Exner T, Rickard KA, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioral patterns. Br J Haematol. 1978;40:143-51.
4. Koike T, Sueshi M, Funaki H, Tomioka H, Yoshida S. Antiphospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin Exp Immunol. 1984;56:193-9.
5. Dupont AG, Van der Niepen P, Sennesael J, Somers G. Diabetic microangiopathic hemolytic anemia: Beneficial effect of an antiplatelet agent? Diabetes Care. 1985;8:169-71.
6. Weinstock RS, Kopecky RT, Jones DB, Sunderji S. Rapid development of nephrotic syndrome, hypertension, and hemolytic anemia early in pregnancy in patients with IDDM. Diabetes Care. 1988;11:416-21.
7. Himeno H, Tsutsu N, Tokunaga T, Nakamura Y. Rapid development of diabetic nephropathy, retinopathy, and hemolytic anemia associated with diabetic microangiopathic hemolytic anemia. The Journal of the Japan Diabetes Society. 1994;37:121-6.
8. Takeda M, Michishita I, Kamon N, Higashifuku Y, Koizumi J, Mabuchi H, et al. A case of insulin-dependent diabetes mellitus associated with diabetic microangiopathic hemolytic anemia. The Journal of the Japan Diabetes Society. 1989;32:121-5.
9. Aoki Y, Yazaki K, Shirotori K, Oguchi H, Kiyosawa K, Furuta S. Insulin-dependent diabetes mellitus showing microangiopathic hemolytic anemia and chronic disseminated intravascular coagulation. Intern Med. 1992;31:1310-2.
10. Del Papa N, Meroni PL, Barcellini W, Borghi MO, Fain C, Khamashta M, et al. Antiphospholipid antibodies cross-reacting with erythrocyte membranes. A case report. Clin Exp Rheumatol. 1992;10:395-9.
11. Cohen MG, Lui SF. Multiple complications of the antiphospholipid syndrome with apparent response to aspirin therapy. J Rheumatol. 1992;15:803-6.
12. Durand JM, Lefevre P, Kaplanski G, Soubeyrand J. Thrombotic microangiopathy and the antiphospholipid antibody syndrome. J Rheumatol. 1991;18:1916-8.
13. Cervera R, Khamashta MA, Font J. Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. Autoimmunity. 1991;11:1-6.
14. Salzman EW, Rosenberg RD, Smith MH, Lindon JN, Favreau L. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest. 1980;65:64-73.